Hirudin Market Report This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin.
Scope of the Report: This report focuses on the Hirudin in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
The Medicines Company Keyken Minapharm Abbott SALUBRIS Pfizer, Inc Teva Pharmaceutical Industries Ltd DUOPUTAI Pentapharm
Market Segment by Countries, covering
China Japan Korea Taiwan Southeast Asia India Australia
Market Segment by Type, covers
Natural Hirudin Recombinant Hirudin
Market Segment by Applications, can be divided into
Thrombosis Disease Tumor Disease Others
To get Sample Report Visit @ https://www.reportsmonitor.com/request-sample/?post=219413 There are 19 Chapters to deeply display the Asia-Pacific Hirudin market. Chapter 1, to describe Hirudin Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Hirudin, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;